Literature DB >> 31058001

Hemophagocytic Lymphohistiocytosis Associated with Natural T-cell Leukemia.

Frank R Ricaurte1, Tariq Kewan2, Pravallika Chadalavada3, Seema Misbah1, Hamed Daw1.   

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening syndrome of excessive immune activation. It can be triggered by a variety of events that disrupt immune homeostasis, infection being the most common of them. We report a case of a 36-year-old male diagnosed with HLH associated with natural T-cell leukemia. The purpose of this report is to call attention to the clinical presentation, diagnosis, and treatment of HLH.

Entities:  

Keywords:  hemophagocytic lymphohistiocytosis; lymphoma; sepsis

Year:  2019        PMID： 31058001      PMCID： PMC6476604          DOI： 10.7759/cureus.4107

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  10 in total

Review 1.  Management of central nervous system lymphomas using monoclonal antibodies: challenges and opportunities.

Authors:  Eric T Wong
Journal:  Clin Cancer Res       Date:  2005-10-01       Impact factor: 12.531

2.  HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society.

Authors:  J I Henter; M Aricò; R M Egeler; G Elinder; B E Favara; A H Filipovich; H Gadner; S Imashuku; G Janka-Schaub; D Komp; S Ladisch; D Webb
Journal:  Med Pediatr Oncol       Date:  1997-05

Review 3.  Hemophagocytic Lymphohistiocytosis: Clinical Presentations and Diagnosis.

Authors:  Kimberly A Risma; Rebecca A Marsh
Journal:  J Allergy Clin Immunol Pract       Date:  2018-12-14

Review 4.  How I treat hemophagocytic lymphohistiocytosis.

Authors:  Michael B Jordan; Carl E Allen; Sheila Weitzman; Alexandra H Filipovich; Kenneth L McClain
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

Review 5.  Hemophagocytic syndrome (HPS) in children and adults.

Authors:  H Tsuda
Journal:  Int J Hematol       Date:  1997-04       Impact factor: 2.490

6.  Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives.

Authors:  K E Sullivan; C A Delaat; S D Douglas; A H Filipovich
Journal:  Pediatr Res       Date:  1998-10       Impact factor: 3.756

Review 7.  Emapalumab: First Global Approval.

Authors:  Zaina T Al-Salama
Journal:  Drugs       Date:  2019-01       Impact factor: 11.431

8.  Hemophagocytic Lymphohistiocytosis: Single-Center Series of 12 Cases from Saudi Arabia.

Authors:  Ghaleb Elyamany; Azzah Alzahrani; Huda Elfaraidi; Omar Alsuhaibani; Nada Othman; Eman Al Mussaed; Fahad Alabbas
Journal:  Clin Med Insights Pediatr       Date:  2016-04-05

9.  Hemophagocytic syndrome masquerading as septic shock: An approach to such dilemma.

Authors:  Zakaria Hindi; Abdallah A Khaled; Ashraf Abushahin
Journal:  SAGE Open Med Case Rep       Date:  2017-12-17

Review 10.  Hemophagocytic lymphohistiocytosis: review of etiologies and management.

Authors:  Melissa R George
Journal:  J Blood Med       Date:  2014-06-12
  10 in total
  1 in total

1.  Comparison of the clinical features and outcome of children with hemophagocytic lymphohistiocytosis (HLH) secondary to visceral leishmaniasis and primary HLH: a single-center study.

Authors:  Mahdi Shahriari; Mohammadreza Bordbar; Hadi Mottaghipisheh; Kurosh Kalantar; Ali Amanati; Mansoureh Shokripour; Omid Reza Zekavat; Soheila Zareifar; Mehran Karimi; Sezaneh Haghpanah
Journal:  BMC Infect Dis       Date:  2021-08-02       Impact factor: 3.090
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.